Forty51 Ventures
VC Fund
Forty51 Ventures is a VC fund focused on Therapeutics and Medical. Forty51 Ventures is the Biotech Venture Capital.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Forty51 Ventures invests in
Stages Forty51 Ventures invests in
Countries Forty51 Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $3.5M–$5.1M
Investment Focus
Industry
- Therapeutics 2 (29%)
- Medical 1 (14%)
- Health Care 1 (14%)
- Biotechnology 1 (14%)
Stage
- Seed 4 (57%)
- Series A 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Tamas Schweighoffer
Partner
|
Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Ferrosa Therapeutics is a Basel, Switzerland-based biotechnology company developing a first-in-class bispecific antibody to treat anemia of inflammation. | $3.5M / Seed / Apr 23, 2026 | |
|
|
Allegria Therapeutics operates as a biotech company. | $5.1M / Seed / Dec 11, 2025 | |
|
|
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. | $80M / Series A / Jun 09, 2025 | |
|
|
Allegria Therapeutics operates as a biotech company. | $3.5M / Seed / May 06, 2024 | |
|
|
Mysthera Therapeutics is a pharmaceutical company Mysthera plans to reshape the treatment landscape for autoimmune disease. PIM kinase inhibition uniquely and selectively modulates immune cell function in multiple lineages associated with complex disease. | $3.5M / Seed / Aug 21, 2023 | |
|
|
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. | Seed / Apr 11, 2023 | |
|
|
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. | Seed / Jul 13, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Forty51 Ventures invest in?
Forty51 Ventures invests primarily in Therapeutics, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Forty51 Ventures's check size?
Forty51 Ventures typically joins rounds of $3.5M–$5.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Forty51 Ventures participates in.
How do I contact Forty51 Ventures?
Public channels for Forty51 Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Forty51 Ventures?
The team at Forty51 Ventures includes Tamas Schweighoffer (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!